Thomas Strecker
Overview
Explore the profile of Thomas Strecker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
2671
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Thom R, Tipton T, Strecker T, Hall Y, Bore J, Maes P, et al.
Lancet Infect Dis
. 2020 Oct;
21(4):507-516.
PMID: 33065039
Background: The 2013-16 Ebola virus disease epidemic in west Africa caused international alarm due to its rapid and extensive spread resulting in a significant death toll and social unrest within...
22.
Steeds K, Hall Y, Slack G, Longet S, Strecker T, Fehling S, et al.
Sci Rep
. 2020 Sep;
10(1):14289.
PMID: 32868837
Ebola virus (EBOV) is an enveloped, single-stranded RNA virus that can cause Ebola virus disease (EVD). It is thought that EVD survivors are protected against subsequent infection with EBOV and...
23.
Muller H, Fehling S, Dorna J, Urbanowicz R, Oestereich L, Krebs Y, et al.
NPJ Vaccines
. 2020 Aug;
5(1):71.
PMID: 32802410
(LASV) is a rodent-borne arenavirus endemic to several West African countries. It is the causative agent of human Lassa fever, an acute viral hemorrhagic fever disease. To date, no therapeutics...
24.
Stott R, Strecker T, Foster T
Viruses
. 2020 Jul;
12(7).
PMID: 32708250
Endemic to West Africa and South America, mammalian arenaviruses can cross the species barrier from their natural rodent hosts to humans, resulting in illnesses ranging from mild flu-like syndromes to...
25.
Boum Y, Juan-Giner A, Hitchings M, Soumah A, Strecker T, Sadjo M, et al.
Vaccine
. 2020 Jun;
38(31):4877-4884.
PMID: 32499066
Background: As part of a Phase III trial with the Ebola vaccine rVSVΔG-ZEBOV-GP in Guinea, we invited frontline workers (FLWs) to participate in a sub-study to provide additional information on...
26.
Strecker T, Agaimy A, Rosch J, Jasinski D
J Card Surg
. 2020 Apr;
35(6):1337-1339.
PMID: 32333422
No abstract available.
27.
Fischer K, Suluku R, Fehling S, Jabaty J, Koroma B, Strecker T, et al.
Emerg Infect Dis
. 2020 Mar;
26(4):760-763.
PMID: 32186496
Ebola virus (EBOV) is a highly pathogenic zoonotic virus for which the reservoir host has not been identified. To study the role of dogs as potential hosts, we screened 300...
28.
Olayemi A, Adesina A, Strecker T, Magassouba N, Fichet-Calvet E
Biology (Basel)
. 2020 Feb;
9(2).
PMID: 32046182
Lassa fever is a viral hemorrhagic illness responsible for thousands of human deaths in West Africa yearly. Rodents are known as natural reservoirs of the causative Lassa mammarenavirus (LASV) while...
29.
Davis C, Tipton T, Sabir S, Aitken C, Bennett S, Becker S, et al.
Clin Infect Dis
. 2019 Dec;
71(11):2872-2879.
PMID: 31784751
Background: In October 2015, 65 people came into direct contact with a healthcare worker presenting with a late reactivation of Ebola virus disease (EVD) in the United Kingdom. Vaccination was...
30.
Strecker T, Nooh E, Marwan M, Agaimy A
J Card Surg
. 2019 Nov;
34(12):1645-1646.
PMID: 31705813
No abstract available.